David A. Zilberberg
Lawyers

Filters
Campbell Soup $1 billion senior notes offering
Davis Polk advised the representatives of the underwriters in connection with a $1 billion SEC-registered debt offering by Campbell Soup Company, consisting of $500 million of its 2.375%…
Energizer $250 million senior notes reopening
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Holdings, Inc. of an additional $250 million aggregate…
South Jersey Industries $200 million at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by South Jersey Industries, Inc. of shares of its common stock for up to an aggregate…
PPL Capital Funding $1 billion senior notes offering
Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $1.0 billion aggregate principal amount of 4.125% senior notes due 2030, fully and unconditionally guaranteed by…
Huntington Ingalls Industries $1 billion senior notes offering
Davis Polk advised the representatives of the several initial purchasers, in a Rule 144A/Regulation S offering by Huntington Ingalls Industries, Inc. of $500 million aggregate…
Weyerhaeuser $750 million bond offering
Davis Polk advised the joint book-running managers, in connection with an SEC-registered offering by Weyerhaeuser Company of $750 million aggregate principal amount of its 4.00% senior…
Honeywell International €1 billion notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €500 million aggregate principal amount of its 0.000…
Canadian Pacific Railway $500 million notes offering
Davis Polk advised the joint book-running managers in connection with the offering by Canadian Pacific Railway Company of $500 million aggregate principal amount of 2.05% notes due…
BioXcel Therapeutics $73.6 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…
TFI International $230 million U.S. IPO
Davis Polk advised the lead book-running managers in connection with the initial U.S. public offering of 6,000,000 common shares of TFI International, Inc. In addition, the underwriters…